Kenneth Vielsted Christensen (Kenneth V Christensen)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Venues

Movement disorders : official journal of the Movement Disorder Society

Journal of medicinal chemistry

eNeuro

Institut de recherches Servier Croissy-sur-Seine

Københavns Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut de recherches Servier Croissy-sur-Seine

France

Project Director :: Neuroscience

H Lundbeck A/S

Denmark

Principal Scientist :: Neurodegeneration

H Lundbeck A/S

Denmark

Industrial PhD student

Aarhus Universitet

Denmark

Research Assistent

Education History

Københavns Universitet

Denmark

PHD

Aarhus Universitet

Denmark

MSC

Publications

Peter A LeWitt, Glenn T Stebbins, Kenneth Vielsted Christensen, Riswanto Tan, Anél Pretorius, Mikael Thomsen
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study. Movement disorders : official journal of the Movement Disorder Society 39 (3) (2024)
Peter A LeWitt, Glenn T Stebbins, Kenneth Vielsted Christensen, Riswanto Tan, Anél Pretorius, Mikael Thomsen
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study. Movement disorders : official journal of the Movement Disorder Society 39 (3) (2024)
Peter A LeWitt, Glenn T Stebbins, Kenneth Vielsted Christensen, Riswanto Tan, Anél Pretorius, Mikael Thomsen
Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study. Movement disorders : official journal of the Movement Disorder Society (2024)
Douglas S Williamson, Garrick P Smith, Gitte K Mikkelsen, Thomas Jensen, Pamela Acheson-Dossang, Lassina Badolo, Simon T Bedford, Victoria Chell, I-Jen Chen, Pawel Dokurno, Morten Hentzer, Samantha Newland, Stuart C Ray, Terry Shaw, Allan E Surgenor, Lindsey Terry, Yikang Wang, Kenneth Vielsted Christensen
Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. Journal of medicinal chemistry 64 (14) (2021)
Michael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, Lassina Badolo, Ross Jeggo, Garrick Paul Smith, Kenneth Vielsted Christensen
Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and Implications. eNeuro 6 (6) (2019)
Douglas S Williamson, Garrick P Smith, Pamela Acheson-Dossang, Simon T Bedford, Victoria Chell, I-Jen Chen, Justus C A Daechsel, Zoe Daniels, Laurent David, Pawel Dokurno, Morten Hentzer, Martin C Herzig, Roderick E Hubbard, Jonathan D Moore, James B Murray, Samantha Newland, Stuart C Ray, Terry Shaw, Allan E Surgenor, Lindsey Terry, Kenneth Thirstrup, Yikang Wang, Kenneth Vielsted Christensen
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1). Journal of medicinal chemistry 60 (21) (2017)

Kenneth Vielsted Christensen.css-eqlu8i{font-size:small;padding-left:4px;} (Kenneth V Christensen)

Publication Activity (10 Years)

Top Topics

Top Venues

Kenneth Vielsted Christensen (Kenneth V Christensen)